Clinical Trials Browser

Phase 2 × brexucabtagene autoleucel × 30 days × Clear all

Lymphoma, Mantle-Cell

Burkitt Lymphoma, Leukemia, Hairy Cell, Waldenstrom Macroglobulinemia, Recurrence